drugset / Trial / NCT06925490

Comparison of 3Mixtatin Pulpotomy and Metapex Pulpectomy in Primary Molars With Irreversible Pulpitis

NCT06925490

Phase 1 Not yet recruiting 50 enrolled Cairo University
RandomizedParallel-groupDouble-blindTreatment

Summary

The present study aims to evaluate the clinical and radiographic success of pulpotomy using 3Mixtatin versus pulpectomy using Metapex in primary molars with irreversible pulpitis in children aged 4 to 9 years.

Timeline

Start
2025-06
Primary completion
2026-09
Completion
2026-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Cefixime Other / unclassified
Subject Ciprofloxacin Small molecule
Comparator Metapex Unknown
Subject Metronidazole Small molecule
Subject Simvastatin Small molecule

Indications